Comparative blanching activities of locally manufactured proprietary fluocinolone acetonide topical preparations. 1979

G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer

The blanching activities and hence the bio-availabilities of the cream and ointment formulations of Synalar and Cortoderm (fluocinolone acetonide 0,025%) were evaluated using an occluded and unoccluded blanching assay. Statistical analysis showed significant differences between similar formulations of fluocinolone acetonide.

UI MeSH Term Description Entries
D008297 Male Males
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005446 Fluocinolone Acetonide A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) Fluortriamcinolone Acetonide,Alvadermo,Capex,Co-Fluocin,Cortiespec,Derma-Smooth FS,Flucinar,Fluocid,Fluodermo,Fluonid,Fluotrex,Flurosyn,Flusolgen,Gelidina,Jellin,Jellisoft,Synalar,Synalar-HP,Synamol,Synemol,Acetonide, Fluocinolone,Acetonide, Fluortriamcinolone,Co Fluocin,Derma Smooth FS,Synalar HP
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000277 Adjuvants, Pharmaceutic Agents that aid or increase the action of the principle drug (DRUG SYNERGISM) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (PHARMACOKINETICS) in such a way as to enhance its effects. Adjuvant, Pharmaceutic,Adjuvant, Pharmaceutical,Adjuvants, Pharmaceutical,Pharmaceutic Adjuvant,Pharmaceutic Adjuvants,Pharmaceutical Adjuvant,Pharmaceutical Adjuvants
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012880 Skin Pigmentation Coloration of the skin. Skin Color,Skin Tone,Color, Skin,Colors, Skin,Pigmentation, Skin,Pigmentations, Skin,Skin Colors,Skin Pigmentations,Skin Tones,Tone, Skin,Tones, Skin

Related Publications

G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
January 1978, Dermatologica,
G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
April 1962, Bulletin of the School of Medicine (Baltimore, Md.),
G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
July 1963, Hospital (Rio de Janeiro, Brazil),
G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
January 1968, Annali di laringologia, otologia, rinologia, faringologia,
G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
December 1973, The Journal of pharmacy and pharmacology,
G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
December 1962, Current therapeutic research, clinical and experimental,
G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
December 1963, Current therapeutic research, clinical and experimental,
G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
December 1961, Archives of dermatology,
G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
December 2004, The Journal of dermatological treatment,
G L Coleman, and A D Magnus, and J M Haigh, and I Kanfer
January 1963, Archives of dermatology,
Copied contents to your clipboard!